Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)

China flag China · Delayed Price · Currency is CNY
1.840
-0.060 (-3.16%)
May 20, 2026, 1:55 PM CST
Market Cap5.00B -15.9%
Revenue (ttm)25.24B -14.8%
Net Income-572.28M
EPS-0.22
Shares Out2.63B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume270,319,725
Average Volume66,991,688
Open2.000
Previous Close1.900
Day's Range1.810 - 2.000
52-Week Range1.810 - 5.700
Beta0.31
RSI19.26
Earnings DateApr 30, 2026

About SHE:000078

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine maleate tablets, estazolam tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work. It also distributes drugs, medical devices, and other medical supplies; and offers value-added services for ho... [Read more]

Sector Healthcare
Founded 1992
Employees 8,264
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000078
Full Company Profile

Financial Performance

In 2025, SHE:000078's revenue was 26.67 billion, a decrease of -12.04% compared to the previous year's 30.32 billion. Losses were -563.06 million, -52.82% less than in 2024.

Financial Statements